Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings

Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings

Background The efficacy of nifekalant in preexcited atrial fibrillation (AF) has not been assessed. Methods and Results The study populations consisted of patients with sustained preexcited AF (n=51), paroxysmal supraventricular tachycardia (n=201), and persistent AF (n=87). Effects of intravenous i...

Full description

Bibliographic Details
Main Authors: Jinzhu Hu, Jianhua Yu, Qi Chen, Jianxin Hu, Qianghui Huang, Zhen Xia, Zirong Xia, Zhenzhen Ju, Ping Yuan, Siyang Fan, Qinmei Xiong, Bo Zhu, Lin Huang, Chunjiao You, Huihui Bao, Yanqing Wu, Xiaoshu Cheng, Juxiang Li, Ali J. Marian, Kui Hong
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
efficacy
nifekalant
Wolff‐Parkinson‐White syndrome
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.012511

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.012511

Similar Items